Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial

被引:0
作者
Eleonora Aricò
Luciano Castiello
Laura Bracci
Francesca Urbani
Flavia Lombardo
Ilaria Bacigalupo
Antonio Ancidoni
Nicola Vanacore
Alessandro Falcione
Chiara Reggiani
Giovanni Marco Dutti
Maria Grazia Maglie
Ombretta Papa
Pier Luigi Bartoletti
Giuseppina Ozzella
Nazario Bevilacqua
Emanuele Nicastri
Filippo Belardelli
Giuseppe Sconocchia
机构
[1] Istituto Superiore di Sanità,FaBioCell, Core Facilities
[2] Istituto Superiore di Sanità,Department of Oncology and Molecular Medicine
[3] II University of Rome “Tor Vergata”,Medical Biotechnology and Translational Medicine PhD School
[4] Istituto Superiore di Sanità,National Centre for Disease Prevention and Health Promotion
[5] Special Units for Regional Continued Care (USCAR),undefined
[6] Institute of Translational Pharmacology,undefined
[7] National Research Council,undefined
[8] National Institute for Infectious Diseases “Lazzaro Spallanzani”,undefined
来源
Trials | / 22卷
关键词
COVID-19; Randomised controlled trial; protocol; Interferon-beta; antiviral; immunomodulation; non-hospitalized patients;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
empty
未找到相关数据